These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15885232)

  • 1. The quantification of cytochrome P-450 (CYP 3A4) mRNA in the blood of patients with viral liver diseases.
    Horiike N; Abe M; Kumagi T; Hiasa Y; Akbar SM; Michitaka K; Onji M
    Clin Biochem; 2005 Jun; 38(6):531-4. PubMed ID: 15885232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease.
    Kato N; Yokosuka O; Hosoda K; Ito Y; Ohto M; Omata M
    Hepatology; 1993 Jul; 18(1):16-20. PubMed ID: 8392026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma.
    Okubo M; Shiota G; Kawasaki H
    Clin Sci (Lond); 2000 Sep; 99(3):207-14. PubMed ID: 11787473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
    Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
    J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of cytochromes P450 1A2, 2E1, and 3A4 and drug transporters Na+-taurocholate-cotransporting polypeptide, organic cation transporter 1, and organic anion-transporting peptide-C correlates with the progression of liver fibrosis in chronic hepatitis C patients.
    Nakai K; Tanaka H; Hanada K; Ogata H; Suzuki F; Kumada H; Miyajima A; Ishida S; Sunouchi M; Habano W; Kamikawa Y; Kubota K; Kita J; Ozawa S; Ohno Y
    Drug Metab Dispos; 2008 Sep; 36(9):1786-93. PubMed ID: 18515332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues.
    Bièche I; Narjoz C; Asselah T; Vacher S; Marcellin P; Lidereau R; Beaune P; de Waziers I
    Pharmacogenet Genomics; 2007 Sep; 17(9):731-42. PubMed ID: 17700362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis.
    Yao F; Guo JM; Xu CF; Lou YL; Xiao BX; Zhou WH; Chen J; Hu YR; Liu Z; Hong GF
    Clin Chim Acta; 2005 Nov; 361(1-2):119-27. PubMed ID: 15993394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease.
    Villa E; Dugani A; Moles A; Camellini L; Grottola A; Buttafoco P; Merighi A; Ferretti I; Esposito P; Miglioli L; Bagni A; Troisi R; De Hemptinne B; Praet M; Callea F; Manenti F
    Hepatology; 1998 Apr; 27(4):983-8. PubMed ID: 9537437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporating cytochrome P450 3A4 genotype expression and FT-IR/Raman spectroscopy data as means of identification of breast tumors.
    Miller SO; Ewing GP; Howard C; Tachikawa H; Bigler SA; Barber WH; Angel M; McDaniel DO
    Biomed Sci Instrum; 2003; 39():24-9. PubMed ID: 12724863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
    Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
    Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
    Bortolami M; Kotsafti A; Cardin R; Farinati F
    J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of fluorouracil-related genes in chronic viral hepatitis using microdissection.
    Kakinuma D; Yoshida H; Mamada Y; Taniai N; Mizuguchi Y; Takahashi T; Shimizu T; Ishikawa Y; Akimaru K; Naito Z; Tajiri T
    Hepatogastroenterology; 2008; 55(84):826-30. PubMed ID: 18705276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma.
    Wong DK; Yuen MF; Poon RT; Yuen JC; Fung J; Lai CL
    J Hepatol; 2006 Oct; 45(4):553-9. PubMed ID: 16904225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam.
    Toan NL; Song le H; Kremsner PG; Duy DN; Binh VQ; Koeberlein B; Kaiser S; Kandolf R; Torresi J; Bock CT
    Hepatology; 2006 Jun; 43(6):1375-84. PubMed ID: 16729315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.
    Iavarone M; Lampertico P; Iannuzzi F; Manenti E; Donato MF; Arosio E; Bertolini F; Primignani M; Sangiovanni A; Colombo M
    J Viral Hepat; 2007 Feb; 14(2):133-9. PubMed ID: 17244253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma.
    Lu Y; Wu LQ; Lü ZH; Wang XJ; Yang JY
    Chin Med J (Engl); 2007 Jun; 120(12):1042-6. PubMed ID: 17637219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
    Jang JW; Lee YC; Kim MS; Lee SY; Bae SH; Choi JY; Yoon SK
    J Viral Hepat; 2007 Mar; 14(3):169-75. PubMed ID: 17305882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients.
    Zhu R; Zhang HP; Yu H; Li H; Ling YQ; Hu XQ; Zhu HG
    Pathol Res Pract; 2008; 204(10):731-42. PubMed ID: 18597951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.